DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. $(GILD)$ rose 1.21% to $98.38 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.76% to 5,994.57 and Dow Jones Industrial Average falling 0.28% to 44,421.91.
This was the stock's fourth consecutive day of gains.
Gilead Sciences Inc. closed 0.53% short of its 52-week high of $98.90, which the company reached on November 11th.
The stock outperformed some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.18% to $151.87, Pfizer Inc. $(PFE)$ fell 1.21% to $26.20, and Abbott Laboratories $(ABT)$ rose 0.41% to $128.45.
Trading volume (10.5 M) eclipsed its 50-day average volume of 6.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 3, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 03, 2025 16:38 ET (21:38 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。